illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. health care
  6. ›
  7. Fleury
Company logo

Fleury | Sustainability Performance

https://www.fleurysa.ch/

Provider of medical diagnostic and laboratory testing services

1926

Switzerland

10,001+ employees

Hospital & Health Care

$1B - 10B in revenue

$100M - 500M in profitability

Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.

Sustainability Ranking & Industry Benchmark

#8436
Overallⓘ
#189
in Switzerlandⓘ
#87
in Hospital & Health Careⓘ

Sustainability Maturity

ⓘ
​​0123456789​​%

Sustainability Intent

ⓘ

Available in
Scale package

Access
​​0123456789​​%

Industry Rank

90 out of 129

Overview
Environmental
Carbon certificates
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies

Company logo
Cano Health

United States, Health Care, Hospital & Health Care

Company logo
Rici Healthcare

Japan, Health Care, Hospital & Health Care

Company logo
Rede D'Or Sao Luiz

Brazil, Health Care, Hospital & Health Care

Market cap ⓘTotal market value of the company's outstanding shares, calculated by multiplying the share price by the number of shares outstanding.
8.4B$, 2026▼16.6% YoY
Revenue ⓘTotal revenue reported in the company's financial statements for the specified reporting year, reflecting income generated from primary business activities. Expressed in millions of USD.
8.3B$, 2025▼7.3% YoY

Controversy level

Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
  • Fleury SA, Brazilian major diagnostic laboratory medicine network, has faced sustained Brazilian CVM regulatory enforcement scrutiny over the contested 2024 sustained share price volatility amid disclosed material US/Brazilian discretionary diagnostic medicine customer demand normalization, plus periodic class actions over alleged inadequate disclosure of Brazilian healthcare customer compliance practices affecting Brazilian institutional shareholders amid Brazilian healthcare sector regulatory pressure.
Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

 Available
Not committed to key sustainability initiatives

Sustainability employees

ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.

    Available in
    Scale package

    Access
  • Email
  • Email